MedTrace Logo

Cascade CGM 15-day Performance Assessment

NCT04099043 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2020-04-06

No results posted yet for this study

Summary

To validate the feasibility of a 15-day wear period of the Cascade CGM system

Conditions

  • Continuous Glucose Monitoring

Interventions

DEVICE

Cascade Continuous Glucose Monitoring System

Continuous Glucose Monitoring for 15 days

Sponsors & Collaborators

  • WaveForm Technologies Inc.

    lead INDUSTRY

Principal Investigators

  • Maja Navodnik Peložnik, MD · Splošna bolnišnica Celje

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-28
Primary Completion
2019-10-13
Completion
2019-10-13

Countries

  • Slovenia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04099043 on ClinicalTrials.gov